Evidence map›Paper›PMID 21163806›Full record

Trial reportThorax2011

Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies.

P J Castaldi, D L Demeo, C P Hersh, D A Lomas, I C Soerheim, A Gulsvik, P Bakke, S Rennard, P Pare, J Vestbo and 3 more

Open access · bronzeAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Thorax, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 6 countries.

P J CastaldiInstitute for Clinical Researchand Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA. pcastaldi@tuftsmedicalcenter.org
D L Demeo
C P Hersh
D A Lomas
I C Soerheim
A Gulsvik
P Bakke
S Rennard
P Pare
J Vestbo
AATGM Investigators
ICGN Investigators
E K Silverman
Haukeland University Hospital · NOHarvard University · USBrigham and Women's Hospital · USHarvard University Press · USManchester Academic Health Science Centre · GBTufts Medical Center · USUniversity of British Columbia · CAUniversity of Cambridge · GBUniversity of Nebraska–Lincoln · US

Funding

Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1): BPCAUL1RR025752 · NCRR · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2008 to 2011
$17.6M
Statistical GeneticsP01HL083069 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LAZARUS, ROSS · 2007 to 2011
$12.2M
Fine Mapping of COPD Susceptibility GenesR01HL075478 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2004 to 2012
$6.4M
Genetic Determinants of COPD in Diverse Ethnic GroupsR01HL084323 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2010
$2.6M
Predictive Modeling with Clinical and Genomic Data in COPDK08HL102265 · NHLBI · TUFTS MEDICAL CENTER · PI CASTALDI, PETER · 2010 to 2014
$641k
Medical Research Council G0901786NCRR NIH HHS UL1 RR025752NHLBI NIH HHS K08 HL102265NHLBI NIH HHS K08HL102265NHLBI NIH HHS P01 HL083069NHLBI NIH HHS R01 HL075478NHLBI NIH HHS R01 HL084323NHLBI NIH HHS U01 HL089856PHS HHS U01 089856
6 · The paper itself

Abstract

backgroundThe identification of gene-by-environment interactions is important for understanding the genetic basis of chronic obstructive pulmonary disease (COPD). Many COPD genetic association analyses assume a linear relationship between pack-years of smoking exposure and forced expiratory volume in 1 s (FEV(1)); however, this assumption has not been evaluated empirically in cohorts with a wide spectrum of COPD severity.

methodsThe relationship between FEV(1) and pack-years of smoking exposure was examined in four large cohorts assembled for the purpose of identifying genetic associations with COPD. Using data from the Alpha-1 Antitrypsin Genetic Modifiers Study, the accuracy and power of two different approaches to model smoking were compared by performing a simulation study of a genetic variant with a range of gene-by-smoking interaction effects.

resultsNon-linear relationships between smoking and FEV(1) were identified in the four cohorts. It was found that, in most situations where the relationship between pack-years and FEV(1) is non-linear, a piecewise linear approach to model smoking and gene-by-smoking interactions is preferable to the commonly used total pack-years approach. The piecewise linear approach was applied to a genetic association analysis of the PI*Z allele in the Norway Case-Control cohort and a potential PI*Z-by-smoking interaction was identified (p=0.03 for FEV(1) analysis, p=0.01 for COPD susceptibility analysis).

conclusionIn study samples of subjects with a wide range of COPD severity, a non-linear relationship between pack-years of smoking and FEV(1) is likely. In this setting, approaches that account for this non-linearity can be more powerful and less biased than the more common approach of using total pack-years to model the smoking effect.

Indexed as

Polymorphism, Single Nucleotidealpha 1-AntitrypsinDNAFemaleFollow-Up StudiesForced Expiratory VolumeGenome-Wide Association StudyGenotypeHumansIncidenceMaleMiddle AgedNorwayPulmonary Disease, Chronic ObstructiveRespiratory Function TestsRetrospective Studiesalpha 1-AntitrypsinDNA

Identifiers

PMID21163806
PMCPMC3312798
OpenAlexW2111783499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.